Have a personal or library account? Click to login
NPAS2 and PER2 are linked to risk factors of the metabolic syndrome Cover

NPAS2 and PER2 are linked to risk factors of the metabolic syndrome

Open Access
|May 2009

Figures & Tables

Table 1

Genotypes and allele frequencies.

GeneSNPaMutation TypeAllele 1bAllele 2n 1 (freq)Cn 2 (freq)n 11 (freq)n12 (freq)n 22 (freq)
Acads rs1799958missenseGA768 (0.74)266 (0.26)283 (0.55)202 (0.39)32 (0.06)
Ada 22G>AmissenseGA978 (0.95)56 (0.05)461 (0.89)56 (0.11)0
Adcyap1 rs2856966missenseAG850 (0.82)184 (0.18)344 (0.67)162 (0.31)11 (0.02)
Arntl rs6486120intronicGT744 (0.72)290 (0.28)280 (0.54)184 (0.36)53 (0.10)
rs1982350intronicGA587 (0.57)447 (0.43)181 (0.35)225 (0.44)111 (0.21)
rs3816360intronicCT552 (0.53)482 (0.47)152 (0.29)248 (0.48)117 (0.23)
rs2278749intronicCT823 (0.80)211 (0.20)328 (0.63)167 (0.32)22 (0.04)
rs2290035intronicAT595 (0.58)439 (0.42)175 (0.34)245 (0.47)97 (0.19)
Arntl2 rs7958822intronicGA560 (0.54)474 (0.46)147 (0.28)266 (0.51)104 (0.20)
rs4964057intronicTG601 (0.58)433 (0.42)178 (0.34)245 (0.47)94 (0.18)
rs1037921missenseAG947 (0.92)87 (0.08)433 (0.84)81 (0.16)3 (0.01)
rs2306074intronicTC668 (0.65)366 (0.35)213 (0.41)242 (0.47)62 (0.12)
rs35878285mis-senseA1034 (1.00)517(1.00)
Clock rs2412646intronicCT760 (0.74)274 (0.26)280 (0.54)200 (0.39)37 (0.07)
rs11240intronicCG696 (0.67)338 (0.33)227 (0.44)242 (0.47)48 (0.09)
rs2412648intronicTG654 (0.63)380 (0.37)210 (0.41)234 (0.45)73 (0.14)
rs3805151intronicTC613 (0.59)421 (0.41)183 (0.35)247 (0.48)87 (0.17)
Cry2 rs2863712missenseT1034 (1.00)517(1.00)
Drd2 rs1800497missenseGA838 (0.81)196 (0.19)336 (0.65)166 (0.32)15 (0.03)
rs6277silentGA542 (0.52)492 (0.48)141 (0.27)260 (0.50)116 (0.22)
Fdft1 rs11549147missenseAG944 (0.91)90 (0.09)431 (0.83)82 (0.16)4 (0.01)
Glo1 rs2736654missenseTG662 (0.64)372 (0.36)207 (0.40)248 (0.48)62 (0.12)
Opn4 rs1079610missenseTC714 (0.69)320 (0.31)246 (0.48)222 (0.43)49 (0.09)
Ncoa3 rs6094752missenseCT1003 (0.97)31 (0.03)486 (0.94)31 (0.06)0
rs2230782missenseGC932 (0.9)102 (0.1)422 (0.82)88 (0.17)7 (0.01)
rs2230783missenseT1034 (1.00)517(1.00)
Npas2 rs11541353missenseCT859 (0.83)175 (0.17)358 (0.69)143 (0.28)16 (0.03)
rs2305160missenseGA727 (0.7)307 (0.3)252 (0.49)223 (0.43)42 (0.08)
Npy rs16139missenseTC956 (0.92)78 (0.08)444 (0.86)68 (0.13)5 (0.01)
Per2 rs934945missenseCT917 (0.89)117 (0.11)402 (0.78)113 (0.22)2 (0.004)
10870intronicAG854 (0.83)180 (0.17)350 (0.68)154 (0.30)13 (0.03)
rs2304672UTR 5'GC865 (0.84)169 (0.16)361 (0.70)143 (0.28)13 (0.03)
S662GmissenseT1034 (1.00)517(1.00)
Plcb4 rs6077510missenseAG552 (0.53)482 (0.47)142 (0.27)268 (0.52)107 (0.21)
Timeless rs2291739missenseAG624 (0.6)410 (0.4)193 (0.37)238 (0.46)86 (0.17)
rs2291738intronicCT546 (0.53)488 (0.47)147 (0.28)252 (0.49)118 (0.23)
Vip rs3823082intronicCT854 (0.83)180 (0.17)351 (0.68)152 (0.29)14 (0.03)
rs688136UTR 3'TC676 (0.65)358 (0.35)221 (0.43)234 (0.45)62 (0.12)
Vipr2 rs885863UTR 3'TC518 (0.50)516 (0.50)126 (0.24)266 (0.51)125 (0.24)

a) dbSNP symbols http://www.ncbi.nlm.nih.gov/SNP

b) Alleles extracted from HapMap http://www.HapMap.org

c) Total number of alleles in study sample, frequencies in parenthesis.

Table 2

Results from one-SNP analysis.

VariableGeneSNPP-valueP-value corrected for multiple testingBeta-coefficient95% CI
Fasting blood glucose level (Logarithmic) a Per2 #108700.0020.049-0.010-0.016–-0.035
VariableGeneSNPP-valueP-value corrected for multiple testingOdds ratio95% CI
High blood pressure b Npas2 rs115413530.0010.020.540.37–0.79
High blood pressure or hypertension medication c Npas2 rs11541353<0.0010.0150.530.36–0.77

Single SNPs were analyzed using linear regression for continuous variables and logistic regression for dichotomous variables. Betacoefficients were calculated for continuous variables, odds ratios for dichotomous variables. The sex and age were controlled for these analyses. P-values corrected for multiple testing were calculated.

a) The concentrations of blood glucose (mmol/L) after fasting at least 4 hours and without drinking on the same day. The variable was log-transformed to obtain the normal distribution.

b) The blood pressure was defined high when systolic pressure was 140 mmHg or higher or diastolic pressure was 90 mmHg or higher.

c) High blood pressure (b) or treatment for previously diagnosed hypertension.

Table 3

Single SNP analysis with corrected p- values = 0.10.

VariableGeneSNPP-valueP-value corrected for multiple testingBeta- coefficient95% CI
Fasting blood glucose level (Logarithmic) a DRD2 rs62770.0030.051-0.008-0.012–-0.003
Waist circumference b PLCB4 rs60775100.0040.0852.00.63–3.4
VariableGeneSNPP-valueP-value corrected for multiple testingOdds ratio95% CI
High waist circumference c Per2 rs9349450.0030.0621.91.2–3.0
Low HDL cholesterol d Vipr2 rs8858630.0040.0691.51.1–2.0
Metabolic syndrome [IDF] f Per2 rs9349450.0040.0701.91.2–2.9

Single SNPs were analyzed using linear regression for continuous variables and logistic regression for dichotomous variables. Betacoefficients were calculated for continuous variables, odds ratios for dichotomous variables. The sex and age were controlled for these analyses. P-values corrected for multiple testing were calculated.

a) The concentrations of blood glucose (mmol/L) after fasting at least 4 hours and without drinking on the same day. The variable was log-transformed to obtain the normal distribution.

b) Waist circumference in centimeters

c) Waist circumference 94 cm or more for men or 80 cm or more for women

d) Serum high-density lipoprotein (HDL) cholesterol level was considered low when it was lower than 1.02 mmol/l for men or lower than 1.29 mmol/l for women.

f) Metabolic syndrome was assessed using the International Diabetes Federations (IDF) criteria [IDF 2005] and defined as having waistline of 94 cm or more for men or 80 cm or more for women and at least two of the following components: the serum triglycerides level 1.7 mmol/l or higher, the serum high-density lipoprotein cholesterol level lower than 1.02 mmol/l for men or lower than 1.29 mmol/l for women, high blood pressure in terms of systolic pressure 130 mmHg or more or diastolic pressure 85 mmHg or more or treatment for previously diagnosed hypertension and raised fasting plasma glucose level 5.6 mmol/l or higher, or previously diagnosed type 2 diabetes.

Language: English
Published on: May 26, 2009
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2009 Ani Englund, Leena Kovanen, Sirkku T Saarikoski, Jari Haukka, Antti Reunanen, Arpo Aromaa, Jouko Lönnqvist, Timo Partonen, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.